These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

7954 related items for PubMed ID: 19232159

  • 1. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 2. The ionic control of 1,25-dihydroxyvitamin D3 production in isolated chick renal tubules.
    Bikle DD, Rasmussen H.
    J Clin Invest; 1975 Feb; 55(2):292-8. PubMed ID: 236326
    [Abstract] [Full Text] [Related]

  • 3. Renal bone disorders in children: therapy with vitamin D3 or 1,25-dihydroxycholecalciferol.
    Bulla M, Delling G, Offermann G, Ziegler R, Benz G, Lühmann H, Sanchez de Reutter A, Severin M.
    Proc Eur Dial Transplant Assoc; 1979 Feb; 16():644-8. PubMed ID: 232917
    [Abstract] [Full Text] [Related]

  • 4. Resistance to the phosphaturic and calcemic actions of parathyroid hormone during phosphate depletion. Prevention by 1,25-dihydroxyvitamin D3.
    Gloor HJ, Bonjour JP, Caverzasio J, Fleisch H.
    J Clin Invest; 1979 Mar; 63(3):371-7. PubMed ID: 34630
    [Abstract] [Full Text] [Related]

  • 5. Neurodiagnostic abnormalities in patients with acute renal failure.
    Cooper JD, Lazarowitz VC, Arieff AI.
    J Clin Invest; 1978 Jun; 61(6):1448-55. PubMed ID: 659607
    [Abstract] [Full Text] [Related]

  • 6. [Vitamin D metabolism in kidney insufficiency: disorders of an endocrine regulatory zone].
    Ritz E, Kreusser W, Boland R, Bommer J.
    Klin Wochenschr; 1979 Oct 01; 57(19):1053-9. PubMed ID: 392179
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of a New Oral Vitamin D Receptor Activator (2-Methylene-19-Nor-(20S)-1α,25-Dihydroxyvitamin D3) in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism on Hemodialysis.
    Pandey R, Zella JB, Zhu JG, Plum LA, Clagett-Dame M, Blaser WJ, Bedale W, DeLuca HF, Coyne DW.
    Drugs R D; 2017 Dec 01; 17(4):597-605. PubMed ID: 28905271
    [Abstract] [Full Text] [Related]

  • 8. Long-term administration of vitamin D steroles in incipient and advanced renal failure: effect on bone histology.
    Malluche HH, Ritz E, Werner E, Meyer-Sabellek WA.
    Clin Nephrol; 1978 Dec 01; 10(6):219-28. PubMed ID: 215365
    [Abstract] [Full Text] [Related]

  • 9. [Calcium and phosphorus metabolism in patients on chronic intermittent haemodialysis with different calcium concentrations in the dialysate (author's transl)].
    Kovarik J, Graf H, Stummvoll HK, Wolf A, Pinggera W.
    Wien Klin Wochenschr; 1979 Nov 23; 91(22):765-8. PubMed ID: 516748
    [Abstract] [Full Text] [Related]

  • 10. Interventions for metabolic bone disease in children with chronic kidney disease.
    Hahn D, Hodson EM, Craig JC.
    Cochrane Database Syst Rev; 2015 Nov 12; 2015(11):CD008327. PubMed ID: 26561037
    [Abstract] [Full Text] [Related]

  • 11. Reversal of skeletal resistance to parathyroid hormone in uremia by vitamin D metabolites: evidence for the requirement of 1,25(OH)2D3 and 24,25(OH)2D3.
    Massry SG, Tuma S, Dua S, Goldstein DA.
    J Lab Clin Med; 1979 Jul 12; 94(1):152-7. PubMed ID: 469372
    [Abstract] [Full Text] [Related]

  • 12. Regulation of the metabolism of 25-hydroxyvitamin D3 in primary cultures of chick kidney cells.
    Trechsel U, Bonjour JP, Fleisch H.
    J Clin Invest; 1979 Jul 12; 64(1):206-17. PubMed ID: 109470
    [Abstract] [Full Text] [Related]

  • 13. Conversion from Intravenous Vitamin D Analogs to Oral Calcitriol in Patients Receiving Maintenance Hemodialysis.
    Thadhani RI, Rosen S, Ofsthun NJ, Usvyat LA, Dalrymple LS, Maddux FW, Hymes JL.
    Clin J Am Soc Nephrol; 2020 Mar 06; 15(3):384-391. PubMed ID: 32111702
    [Abstract] [Full Text] [Related]

  • 14. Bone mineral disturbances in patients with chronic kidney disease stage 5 not yet on dialysis.
    Marn Pernat A, Zrimšek M.
    Clin Nephrol; 2020 Mar 06; 88(13):39-43. PubMed ID: 28619127
    [Abstract] [Full Text] [Related]

  • 15. [Corneal deposits in children on dialysis and treatment with vitamin D3 and 1,25 DHCC (author's transl)].
    Severin M, Bulla M.
    Klin Monbl Augenheilkd; 1979 Nov 06; 175(5):670-6. PubMed ID: 232733
    [Abstract] [Full Text] [Related]

  • 16. [Primary hyperparthyroidism. Analysis of 152 patients with special reference to acute life threatening complications (acute hyperparathyroidism)].
    Kistler H.
    Schweiz Med Wochenschr Suppl; 1976 Nov 06; (3):1-61. PubMed ID: 208139
    [Abstract] [Full Text] [Related]

  • 17. [1 alpha-hydroxyvitamin D3: chemical synthesis and biological effect].
    Bauman VK, Bogoslovskiĭ NA, Kisel'nikova TA, Shakhova MK, Valinietse MIu.
    Prikl Biokhim Mikrobiol; 1978 Nov 06; 14(2):243-52. PubMed ID: 208064
    [Abstract] [Full Text] [Related]

  • 18. Vitamin D-resistant rickets. A prototype of nutritional management of a genetic disorder.
    Deluca HF.
    Curr Concepts Nutr; 1979 Nov 06; 8():3-32. PubMed ID: 230941
    [Abstract] [Full Text] [Related]

  • 19. The ionic control of 1,25-dihydroxyvitamin D3 synthesis in isolated chick renal mitochondria. The role of calcium as influenced by inorganic phosphate and hydrogen-ion.
    Bikle DD, Murphy EW, Rasmussen H.
    J Clin Invest; 1975 Feb 06; 55(2):299-304. PubMed ID: 236327
    [Abstract] [Full Text] [Related]

  • 20. The role of 1 alpha, 25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria.
    Kaplan RA, Haussler MR, Deftos LJ, Bone H, Pak CY.
    J Clin Invest; 1977 May 06; 59(5):756-60. PubMed ID: 192763
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 398.